GGrantIndex
← Leaderboards

David Joseph Sullivan

Johns Hopkins University

$9,405,920
Attributed
$13,293,365
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200625
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,293,365 · 8

By mechanism

R01$10,052,651 · 3
T32$1,812,247 · 1
U01$786,371 · 1
R21$612,364 · 1
D71$23,760 · 1
P41$5,972 · 1

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Malaria

Research focus

MalariaQuinolineParasitesErythrocytesDrug ResistanceAntimalarialsPlasmodium FalciparumIn VitroHemeArtemisininsPharmaceutical PreparationsKillingsDoseIn VivoDrug CombinationsPharmacotherapyUptakeCombined Modality TherapyProteinsBaseResponseMolecularCell FractionationCytostatics

Grant awards (32)

Dual artemisinin action combats resistance$569,412
R01 · FY2025 · AI · contact PI
Malaria and Mosquito/Tick-borne Diseases$334,590
T32 · FY2025 · AI · contact PI
Dual artemisinin action combats resistance$569,412
R01 · FY2024 · AI · contact PI
Dual artemisinin action combats resistance$569,412
R01 · FY2023 · AI · contact PI
Malaria and Mosquito-borne Diseases$316,271
T32 · FY2023 · AI · contact PI
Dual artemisinin action combats resistance$569,412
R01 · FY2022 · AI · contact PI
Malaria and Mosquito-borne Diseases$296,484
T32 · FY2022 · AI · contact PI
Dual artemisinin action combats resistance$585,350
R01 · FY2021 · AI · contact PI
Malaria and Mosquito-borne Diseases$285,071
T32 · FY2021 · AI · contact PI
Malaria and Mosquito-borne Diseases$294,728
T32 · FY2020 · AI · contact PI
Malaria and Mosquito-borne Diseases$285,103
T32 · FY2019 · AI · contact PI
Optimized Combination Antimalarial Drug Therapy$923,203
R01 · FY2018 · AI
Optimized Combination Antimalarial Drug Therapy$923,203
R01 · FY2017 · AI
Quantum model repurposing of cethromycin for liver stage malaria$286,198
R21 · FY2017 · TR · contact PI
Optimized Combination Antimalarial Drug Therapy$923,203
R01 · FY2016 · AI
Quantum model repurposing of cethromycin for liver stage malaria$326,166
R21 · FY2016 · TR · contact PI
Optimized Combination Antimalarial Drug Therapy$1,087,190
R01 · FY2015 · AI
Optimized Combination Antimalarial Drug Therapy$1,055,093
R01 · FY2014 · AI
Influence of Iron on Murine Malaria$192,446
U01 · FY2012 · HD · contact PI
Influence of Iron on Murine Malaria$193,925
U01 · FY2011 · HD · contact PI
Influence of Iron on Murine Malaria$200,000
U01 · FY2010 · HD · contact PI
Plasmodium Falciparum Metal Metabolism$325,276
R01 · FY2009 · AI · contact PI
Influence of Iron on Murine Malaria$200,000
U01 · FY2009 · HD · contact PI
Plasmodium Falciparum Metal Metabolism$316,724
R01 · FY2008 · AI · contact PI
Mapping Malaria Control for Clinical, Operation and Health Services Research$23,760
D71 · FY2008 · TW · contact PI
Plasmodium Falciparum Metal Metabolism$314,216
R01 · FY2007 · AI · contact PI
Plasmodium Falciparum Metal Metabolism$330,276
R01 · FY2006 · AI · contact PI
SIZES OF CONFORMATIONAL SPACES IN PROTEINS$5,972
P41 · FY2004 · RR
IRON METABOLISM IN PLASMODIUM$268,685
R01 · FY2003 · AI
IRON METABOLISM IN PLASMODIUM$260,860
R01 · FY2002 · AI
IRON METABOLISM IN PLASMODIUM$253,260
R01 · FY2001 · AI
IRON METABOLISM IN PLASMODIUM$208,464
R01 · FY2000 · AI